Varicella Immunity and History of Infection Maryellen E. Gusic MD Assistant Professor of Pediatrics Penn State Children’s Hospital.

Slides:



Advertisements
Similar presentations
Module 1 Introduction to rotavirus disease and vaccine
Advertisements

Recognition and assessment of coeliac disease Implementing NICE guidance 2009 NICE clinical guideline 86.
Phases of HIV/AIDS 1. Infection 2. Window period 3. Seroconversion 4. Asymptomatic period 5. HIV/AIDS - related illness 6. AIDS.
Feb 2011 Dr Guada Lopez Marti Pediatric Infectious Diseases Marshall University.
UIC College of Nursing Clinical Requirements Immunity Records CPR.
Tuberculosis in Children: Prevention Module 10C - March 2010.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Paul IM, Beiler JS, Vallati JR, Duda LM, King TS
Perinatal Hepatitis B Prevention
Welcome to Journal club Dr. Md. Abul Hossain Khan Honorary Trainee Department of microbiology, MMC A Comparative Study of Typhidot and Widal Test in Patients.
Perinatal Varicella By Rafat Mosalli MD FAAP FRCPC.
What is one of the most contagious diseases? Measles 2015 Dr. Michael Levy.
Swine Flu Guidelines & Recommendations for Preventing Influenza Spread in ChildrenBy Gehan A Alsawah, MD Lecturer of Pediatrics, Pediatric Cardiology.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
© 2010 Baylor College of Medicine Post-18 month confirmatory HIV testing in HIV DNA PCR positive children: retrospective descriptive analysis from an operational.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
By: Whitley Morris and Brandi Hall. If so, contact your doctor immediately. You may have herpes zoster. Also known as shingles.
Lyme’s Disease.
Screening for Autism Spectrum Disorder Autism Case Training: A Developmental-Behavioral Pediatrics Curriculum 1 Authors Rebecca Scharf, MD, Children’s.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
Early detection of pulmonary involvement in scleroderma patients By Mohamed Mostafa Metwally, MD, FCCP Assistant professor of chest diseases Assiut University.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Module II: Diagnosing Paediatric HIV
Bloodborne Pathogens HIV, AIDS, and Hepatitis Unit 1.
Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles) Short.
Chickenpox (varicella)
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
Update: Lowering Measles Antibody Lot Release Specification in IGIV/IGSC Blood Products Advisory Committee May 1, 2008 Dorothy Scott, M.D. Division of.
Herpes Zoster Vaccination Anupama Raghuram, MD Assistant Professor Department of Internal Medicine Division of Infectious Diseases August 7 th, 2013.
Chapter 24; Lesson 3.  Human Immunodeficiency Virus (HIV) – a virus that attacks the immune system.  Once HIV enters the body, it finds and destroys.
Introduction In March of this year, the Center for Disease control estimated the incidence of Autism Spectrum Disorders to be 1 in 50, an increase from.
Pediatric HIV/AIDS: Orphans & Vulnerable Children.
In the name of god.
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Introduction Background : Asthma is a common chronic airway disorder characterized by periods of reversible airflow obstruction known as asthma attack.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
November  HIV stands for Human Immunodeficiency Virus  It is a virus that attacks the immune system and weakens the body’s ability to fight infection.
Early Parental Satisfaction with Pediatric Care: Does it Improve Immunization of Young Children? Ashley Schempf BS, Cynthia Minkovitz MD MPP Donna Strobino.
Favoring factors of deficiency diseases in children Author: Andreea-Iulia Csiszer Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy,
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Specific Aim 1: Determine the impact of psychiatric disorders on the hospital length of stay (LOS) in pediatric patients diagnosed with SCD admitted for.
Dr K N Prasad Community Medicine
WIC Pediatric Referral Form Tutorial
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Screening for Autism Spectrum Disorder Autism Case Training: A Developmental-Behavioral Pediatrics Curriculum 1 Authors Rebecca Scharf, MD, Children’s.
HIV is the virus that causes AIDS, a disease that weakens the body’s immune system and may have fatal consequences.
Chicken pox Prof. Dr. Marlina, MS, Apt..  Chickenpox, also spelled chicken pox, is the common name for Varicella zoster  Classically one of the childhood.
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
Training for rotavirus vaccine introduction Module 1 Introduction to rotavirus disease and vaccine.
Neonatal Varicella Infants whose mothers develop varicella in the period from 5 days prior to delivery to 2 days afterward. High mortality Transplacental,
Recommendations for Postexposure Prophylaxis of Varicella Infection Mona Marin, MD Centers for Disease Control and Prevention Blood Products Advisory Committee.
Scientific Basis for Review of Varicella Zoster Immune Globulin Products Blood Products Advisory Committee July 21, 2005 Dorothy Scott, M.D. OBRR/CBER.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 50 Pediatric Patients.
Presented by: Michelle Montemayor Molly Tor Terrie West Eileen Zuniga Student Health Problems Health Education Standard 3b.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
Should Receiving Vaccinations Be Regulated or Free Choice? Christina Davis, Brianna Schraeder King’s College, Wilkes-Barre PA Aim and Methods Conclusion.
School-Based Varicella Surveillance Palm Beach County, Florida 42 nd National Immunization Conference March 17, 2008 Savita Kumar, MD, MSPH Medical Epidemiologist.
Welcome to the Immunization Requirements Webinar for Clinic Staff! For technical difficulties, call , press 1. During this webinar, everyone.
Management infant born with mother Chickenpox
Varicella & Pregnancy Dr S. Asadi Infectious diseases specialist
Director Medical Services (Health) Office of the DGMS (Army)
Lyme’s Disease.
Lecture 11 serology Lyme’s Disease
The presenter has no conflicts of interest to disclose.
Relationship between CMV & PU disease
ADEIGA.A, AWODERU O.A,FANEYE.A, AKINTUNDE, GB, ONYEWUCHE.J.
Hepatitis Primary Care: Clinics in Office Practice
ImmunoWELL Zika Virus Serology.
Chapter 27 Pediatrics.
Varicella Vaccine Efficacy Estimates
Presentation transcript:

Varicella Immunity and History of Infection Maryellen E. Gusic MD Assistant Professor of Pediatrics Penn State Children’s Hospital

Introduction zImmunization against varicella is recommended for susceptible, immunocompetant children over the age of 12 months. zA reliable history of naturally occurring infection is considered to be evidence of immunity.

Introduction continued zInfection rarely occurs without the development of characteristic skin lesions. zParents are usually able to report a history of varicella infection in their child.

Introduction continued zVaricella immunity requires ydevelopment of specific antibodies ystimulation of cell mediated immunity zImmune status of a child can be determined by measuring specific IgG immunoglobulin levels.

Introduction continued zVaricella in infants yA modified specific antibody and cell mediated immune response has been described. xmild infection xeffect of transplacentally acquired antibodies

Introduction continued zNatural infection is thought to provide life long immunity. zReinfections are observed in healthy children. yinaccurate diagnoses? ymodified antibody and/or cell mediated immune response?

Our Study zHypotheses yChildren infected with varicella early in life may have a modified immune response to infection and remain susceptible to reinfection. yChildren whose infection was clinically mild, may not have developed protective antibody titers and thus also remain susceptible to reinfection.

Objectives zTo identify children with a history of natural infection whose illness occurred before 1 year of age zTo identify children whose infection would be classified as mild or moderate by determining the number of skin lesions present during the illness

Objectives continued zTo determine if children with a history of natural infection before 1 year of age or with mild or moderate infection have protective antibody titers zTo determine if further questions to describe the skin lesions present aid in supporting the “reliability” of the history of infection

Methods zChildren with a history of varicella infection identified by chart review and by parental questioning at clinic visits were included. zChildren with a known immunodeficiency were excluded. zA varicella questionnaire was completed.

Methods continued zVaricella questionnaire ypatient’s current age yage at which varicella infection occurred yinfection diagnosed by parent or health care professional ydescription of illness xvesicular, itchy, number of lesions

Methods continued zFinger stick blood samples were obtained for those children whose infection occurred before one year of age or who had less than 250 lesions during their infection. zSerologic testing for anti-VZV IgG antibodies was performed by the National VZV Lab at the CDC.

Methods continued zSerologic testing yELISA assay for anti-VZV IgG antibodies yResults recorded as mean adjusted OD reading and by objective rating x0.166 and above positive yEquivocal results retested at lower serum dilution

Methods continued zOdds ratios were determined and a Chi square analysis was performed on the data. zResearch was approved by the Institutional Review Board of the Hershey Medical Center and the Penn State University College of Medicine.

Results z32 patients were enrolled in the study y11 children had <50 lesions y21 children had moderate infection y17 children were infected before 1 year of age x5 children whose infection occurred before 1 year of age had mild infection xNo child whose infection occurred before 1 year of age had >250 lesions

Results continued z30 patients underwent serologic testing y4 patients had negative antibody titers y6 patients had equivocal serologic results

Conclusions zChildren with a history of mild varicella infection should be evaluated to determine if they have protective antibody titers. zAn immunocompetant child aged 12 months or older who has negative antibody titers should be immunized against varicella zoster virus.

Conclusions continued zDetermining if the rash associated with the infection was itchy may further support the reliability of the diagnosis. zBoth parents and health care professionals may incorrectly identify an illness as varicella.

Limitations of this Study zPower of study limited by the small number of patients enrolled zResults dependent upon parental reporting of age of infection, symptoms of disease zNegative serologic titers may be result of inaccurate diagnoses

Implications for Future Research zStudies are needed to determine the factors that may interfere with the development of life long protective immunity to varicella infection. zFurther studies identifying the clinical signs and symptoms that ensure the accuracy of diagnosing varicella have important public health considerations.

A Special Thanks to... z Dr. Scott Schmid and the National VZV lab at the CDC zBeth Anne Nagy, MS II, Penn State College of Medicine zDavid Mauger, PhD, Department of Health Evaluation Sciences, Penn State College of Medicine